These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 570205

  • 21. The ability to sensitize host cells for destruction by autologous complement is a general property of lipoteichoic acid.
    Weinreb BD, Shockman GD, Beachey EH, Swift AJ, Winkelstein JA.
    Infect Immun; 1986 Nov; 54(2):494-9. PubMed ID: 3533782
    [Abstract] [Full Text] [Related]

  • 22. Bacterial lipoteichoic acid sensitizes host cells for destruction by autologous complement.
    Hummell DS, Winkelstein JA.
    J Clin Invest; 1986 May; 77(5):1533-8. PubMed ID: 3084560
    [Abstract] [Full Text] [Related]

  • 23. Complement inhibitor(s) released by leukocytes. I. Pretreatment of sheep erythrocytes with supernatants of mouse spleen and thymus cells inhibit whole complement activity and C2 utilization.
    Bernard A, Boumsell L, Borsos T, Good RA, Day NK.
    J Immunol; 1975 Oct; 115(4):1087-90. PubMed ID: 1176766
    [Abstract] [Full Text] [Related]

  • 24. C3-independent immune haemolysis: mechanism of membrane attack complex formation.
    Kitamura H, Tsuboi M, Nagaki K.
    Immunology; 1986 Sep; 59(1):147-51. PubMed ID: 3759127
    [Abstract] [Full Text] [Related]

  • 25. The binding of Pneumococcal lipoteichoic acid to human erythrocytes.
    McCloskey JJ, Szombathy S, Swift AJ, Conrad D, Winkelstein JA.
    Microb Pathog; 1993 Jan; 14(1):23-31. PubMed ID: 8391621
    [Abstract] [Full Text] [Related]

  • 26. A comparison of PCA reactive and hemolytic rabbit antibodies to sheep red blood cells.
    Warner NL, Ovary Z.
    J Immunol; 1970 Jun; 104(6):1429-34. PubMed ID: 5419279
    [No Abstract] [Full Text] [Related]

  • 27. Lysis of sheep red cells in neat autologous serum as a source of antibody and complement.
    Borsos T, Circolo A.
    Acta Pathol Microbiol Immunol Scand Suppl; 1984 Jun; 284():5-9. PubMed ID: 6587743
    [Abstract] [Full Text] [Related]

  • 28. Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.
    McLeod B, Lint TF, Baker P, Behrends C, Gewurz H.
    Immunology; 1975 Apr; 28(4):741-54. PubMed ID: 1171082
    [Abstract] [Full Text] [Related]

  • 29. Complement receptor type three-dependent degradation of opsonized erythrocytes by mouse macrophages.
    Rothlein R, Springer TA.
    J Immunol; 1985 Oct; 135(4):2668-72. PubMed ID: 3897377
    [Abstract] [Full Text] [Related]

  • 30. Preparation and partial characterization of sheep erythrocyte-antibody-complement intermediate.
    Rommel FA, Stolfi R.
    Immunology; 1968 Oct; 15(4):469-79. PubMed ID: 5696260
    [Abstract] [Full Text] [Related]

  • 31. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
    Lint TF, Behrends CL, Baker PJ, Gewurz H.
    J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
    [Abstract] [Full Text] [Related]

  • 32. Complement fixation by rheumatoid factor.
    Tanimoto K, Cooper NR, Johnson JS, Vaughan JH.
    J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
    [Abstract] [Full Text] [Related]

  • 33. Sheep serum complement sensitisation of sheep erythrocyte-rabbit antibody complexes for haemolysis by guinea-pig complement plus EDTA or Mg2+-EGTA.
    Jonas W, Stankiewicz M.
    Arch Immunol Ther Exp (Warsz); 1986 Mar; 34(4):451-60. PubMed ID: 3099725
    [Abstract] [Full Text] [Related]

  • 34. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
    Schönermark S, Filsinger S, Berger B, Hänsch GM.
    Immunology; 1988 Apr; 63(4):585-90. PubMed ID: 3366469
    [Abstract] [Full Text] [Related]

  • 35. An enzyme-linked immunosorbent assay (ELISA) for quantification of antibodies to Streptococcus mutans surface antigens.
    Hamada S, Michalek SM, Torii M, Morisaki I, McGhee JR.
    Mol Immunol; 1983 Apr; 20(4):453-64. PubMed ID: 6408401
    [Abstract] [Full Text] [Related]

  • 36. The indiction by complement of a change in KSCN-dissociable red cell membrane lipids.
    Giavedoni EB, Dalmasso AP.
    J Immunol; 1976 Apr; 116(4):1163-9. PubMed ID: 1254965
    [Abstract] [Full Text] [Related]

  • 37. Immune hemolysis: serial studies of the dissociability of IgG and IgM anti-Forssman antibodies using the C'la fixation and transfer technique.
    Linscott WD.
    J Immunol; 1969 Apr; 102(4):986-92. PubMed ID: 5768199
    [No Abstract] [Full Text] [Related]

  • 38. Characterization of a monoclonal antibody specific for lipoteichoic acid from various gram-positive bacteria.
    Hamada S, Furuta T, Okahashi N, Nisizawa T, Yamamoto T, Chiba J.
    Microbiol Immunol; 1984 Apr; 28(9):1009-21. PubMed ID: 6083437
    [Abstract] [Full Text] [Related]

  • 39. Erythrocyte binding properties of streptococcal lipoteichoic acids.
    Beachey EH, Dale JB, Simpson WA, Evans JD, Knox KW, Ofek I, Wicken AJ.
    Infect Immun; 1979 Mar; 23(3):618-25. PubMed ID: 378832
    [Abstract] [Full Text] [Related]

  • 40. Effect of leukocyte hydrolases on bacteria. IX. The release of lipoteichoic acid from group A streptococci and from Strep. mutans by leukocyte extracts and by lysozyme: relation to tissue damage in inflammatory sites.
    Sela MN, Lahav M, Ginsburg I.
    Inflammation; 1977 Jun; 2(2):151-64. PubMed ID: 33119
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.